CAMLX | GAFFX | CAMLX / GAFFX | |
Total Expense Ratio | 0.93 | 0.30 | 310% |
Annual Report Gross Expense Ratio | 0.93 | 0.30 | 310% |
Fund Existence | 16 years | 8 years | - |
Gain YTD | 0.474 | 5.197 | 9% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 547M | 306B | 0% |
Annual Yield % from dividends | 0.00 | 0.65 | - |
Returns for 1 year | 1.61 | 7.65 | 21% |
Returns for 3 years | 45.52 | 54.61 | 83% |
Returns for 5 years | 37.56 | 51.03 | 74% |
Returns for 10 years | 109.00 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JHQAX | 32.71 | -0.12 | -0.37% |
JPMorgan Hedged Equity A | |||
AHSCX | 11.37 | -0.06 | -0.52% |
Alger Health Sciences C | |||
BRULX | 15.81 | -0.19 | -1.19% |
MFS Blended Research Value Equity R3 | |||
GSIKX | 20.78 | -0.26 | -1.24% |
Goldman Sachs International Eq Inc Instl | |||
GSQRX | 30.77 | -0.56 | -1.79% |
Goldman Sachs Small Cap Value R |